What are the clinical symptoms of gastroparesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Clinical Symptoms of Gastroparesis

The cardinal symptoms of gastroparesis are nausea and vomiting, which are often accompanied by early satiety, postprandial fullness, abdominal pain, and bloating 1, 2.

Primary Symptom Constellation

The symptom profile of gastroparesis includes:

  • Nausea and vomiting - These are the defining cardinal symptoms that most reliably correlate with the diagnosis 1, 2
  • Early satiety - Feeling full shortly after beginning a meal 1, 3
  • Postprandial fullness - Uncomfortable fullness after eating that persists 1, 3
  • Abdominal pain - Present in many patients, though when this is the predominant symptom, alternative diagnoses should be carefully excluded 1
  • Bloating - A common accompanying symptom 1, 4

Important Clinical Distinctions

Vomiting severity is the symptom most significantly associated with objectively delayed gastric emptying 5. A recent 2024 study found that among all gastroparesis symptoms, only vomiting severity was significantly higher in patients with documented delayed gastric emptying compared to those with normal emptying (p = 0.01).

Weight loss is another important clinical feature, with patients having delayed gastric emptying showing significantly greater weight loss (9.4 kg vs. 5.6 kg) 5.

Symptom Overlap and Diagnostic Challenges

The symptoms of gastroparesis frequently overlap with functional dyspepsia, particularly postprandial distress syndrome 2. This overlap makes clinical diagnosis challenging based on symptoms alone, which is why objective testing of gastric emptying is required for definitive diagnosis 1, 2.

The Gastroparesis Cardinal Symptom Index (GCSI) score, while higher in patients with delayed emptying, does not have a clinically relevant threshold to discriminate between normal and delayed gastric emptying 5. This reinforces that symptoms alone cannot reliably diagnose gastroparesis without objective gastric emptying testing.

Clinical Predictors

Certain clinical factors increase the likelihood of finding delayed gastric emptying when symptoms are present:

  • Diabetes mellitus (60% prevalence of delayed emptying) 5
  • History of gastric surgery (78% prevalence of delayed emptying) 5
  • Older age 5
  • Presence of vomiting 5
  • Greater weight loss 5

References

3
Research

2023 update on the clinical management of gastroparesis.

Expert review of gastroenterology & hepatology, 2023

Related Questions

What are the symptoms of post‑viral gastroparesis accompanied by chronic fatigue?
What analgesic options can be given to a patient with gastroparesis who is unable to tolerate oral intake?
What are the causes of gastroparesis?
How do gastroparesis and delayed gastric emptying cause throat mucus, and how should it be managed?
What pain medications are appropriate for a patient with gastroparesis?
What is the appropriate treatment regimen for Evan's syndrome, including first‑line therapy, dosing, and second‑line options?
What do ACTH (adrenocorticotropic hormone) and prolactin levels measure?
How do I calculate the tirofiban infusion rate (loading and maintenance) for a patient?
In a 45-year-old outpatient scheduled for computed tomography with iodinated contrast media who has never received contrast and has a mild shellfish allergy causing throat itching, do the American College of Radiology and American Academy of Allergy, Asthma & Immunology guidelines recommend premedication?
In a 45-year-old male with prediabetes, dyslipidemia, hypertension, and daily alcohol consumption of 42 g, which term most specifically describes his steatotic liver disease according to the American Diabetes Association (ADA) consensus report on screening for metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes?
What is a brand-name vaginal moisturizer containing polycarbophil (generic: polycarbophil)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.